Xeomin 200 LD50-Einheiten, Pulver zur Herstellung einer Injektionslösung
7680620800032
CH-62080
Pulver
Associated product:
XEOMIN 200 LD50 Einheiten subst seche 200 U.I. 1 p
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Pulver
- Galenic group
- Lösbar zur Einnahme
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
toxinum botulinicum A (150 kDa)
|
200.0 UI | Substance | Wirkstoff (Principe actif) |
|
saccharum
|
- | Substance | HNIDK |
|
albuminum humanum
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 443.55
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/09/2026
Authorization holder
Merz Pharma (Schweiz) AG
4123 Allschwil
Authorization information
- Swissmedic authorization number
- 62080
- Drug name
- Xeomin, Pulver zur Herstellung einer Injektionslösung
- Galenic form
- PULVL
- ATC Code
- M03AX01
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 12/04/2013
- Authorization expiration date
- 31/12/9999
- IT Number
- 01.13.0.
- Domain
- Human medicine
Package details
- Description (FR)
- XEOMIN 200 LD50 Einheiten subst seche 200 U.I. 1 p
- Description (DE)
- XEOMIN 200 LD50 Einheiten Trockensub 200 U.I. 1 St
- Market launch
- 01/09/2026
- Narcotic (BTM)
- No